Skip Over Navigation Links


TRND Information


NIH announces start of clinical trial using cyclodextrin as a potential treatment for Niemann-Pick disease, type C1 — a rare, fatal neurological disorder. The collaborative phase I trial, which stems from pilot work pursued by NCATS' Therapeutics for Rare and Neglected Diseases program, will test the drug in nine patients.

Learn how you can participate in clinical trials - National Institutes of Health